Efficacy and Safety Analysis of Upadacitinib in Inflammatory Bowel Disease

NCT06274996 · clinicaltrials.gov ↗

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases

Interventions

DRUG: Upadacitinib

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University